Eve Burstein
Stock Analyst at Bernstein
(1.63)
# 3,161
Out of 4,843 analysts
22
Total ratings
38.46%
Success rate
-0.05%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $135 → $145 | $111.92 | +29.56% | 3 | Jan 10, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $157.73 | +26.80% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $90.42 | +60.36% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $349.24 | +3.08% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $56.28 | +59.91% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $40.62 | -13.84% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $402.82 | +53.91% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $0.96 | +159.42% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $12.91 | +70.41% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $82.24 | +34.97% | 1 | Sep 28, 2023 |
Agilent Technologies
Jan 10, 2025
Maintains: Market Perform
Price Target: $135 → $145
Current: $111.92
Upside: +29.56%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $157.73
Upside: +26.80%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $90.42
Upside: +60.36%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $349.24
Upside: +3.08%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $56.28
Upside: +59.91%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $40.62
Upside: -13.84%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $402.82
Upside: +53.91%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $0.96
Upside: +159.42%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $12.91
Upside: +70.41%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $82.24
Upside: +34.97%